V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270010864 | 270006401 | 1.74 | null | Disease modification (D) | 2017-12-15 | 2017-12-16 | ChIVPP/EVA | N | N | 270023796 | ATG + BUSULFAN + FLUDARABINE |
| 270010865 | 270006402 | 1.8 | 101 | Curative (C) | 2015-11-21 | 2015-11-28 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | 270023834 | CISPLATIN + ETOPOSIDE |
| 270010866 | 270006403 | 1.75 | 70.4 | Palliative (P) | 2015-02-25 | 2015-03-04 | Cetuximab +Cisplatin + FU (Cycle 1) | 02 | null | 270023889 | CISPLATIN + VINORELBINE |
| 270010867 | 270006404 | 1.8 | 79.9 | Palliative (P) | 2017-11-25 | 2017-12-07 | Capecitabine + Cisplatin | N | N | 270023944 | ABIRATERONE |
| 270010868 | 270006405 | 1.61 | 69.7 | Palliative (P) | 2016-04-07 | 2016-04-09 | Carboplatin AUC 2 - 5 | 02 | N | 270023952 | CAP + RT |
| 270010869 | 270006406 | 1.59 | 96 | Adjuvant (A) | 2013-10-21 | 2013-10-21 | Cetuximab + Radiotherapy Load | 2 | N | 270024030 | CETUXIMAB + RT |
| 270010870 | 270006407 | 1.65 | 38.2 | Not known (9) | 2018-03-12 | 2018-03-26 | CAP + RT | 2 | Y | 270024040 | FLUOROURACIL + RT |
| 270010871 | 270013074 | 1.73 | null | Curative (C) | 2016-11-13 | 2016-11-14 | GemCarbo Days 1+8 | N | N | 270024082 | CARBO + FLUOROURACIL |
| 270010872 | 270013074 | 1.6 | 84.2 | Palliative (P) | 2017-05-19 | 2017-06-03 | FLUOROURACIL + MITOMYCIN + RT | N | N | 270024082 | CETUXIMAB + OXALIPLATIN + MDG |
| 270010873 | 270006408 | 1.83 | 60 | null | 2017-05-05 | 2017-05-06 | Cetuximab + Radiotherapy Load | 02 | N | 270024199 | CETUXIMAB + RT |
| 270010874 | 270006409 | 1.68 | 72.9 | Adjuvant (A) | null | 2017-02-19 | Ralitrexed | null | null | 270024288 | CETUXIMAB |
| 270010875 | 270006410 | 1.62 | 70.6 | Adjuvant (A) | 2017-01-15 | 2017-01-21 | Cetuximab + FLUOROURACIL + FOLINIC ACID + OXALIPLATIN | 2 | N | 270024316 | CISPLATIN + PEMETREXED |
| 270010876 | 270006411 | 1.81 | null | Palliative (P) | 2017-07-16 | 2017-08-10 | Ralitrexed | N | N | 270024364 | CARBOPLATIN + ETOPOSIDE |
| 270010877 | 270006412 | 1.78 | null | Curative (C) | 2016-04-22 | 2016-05-02 | Carboplatin AUC 2 - 5 | N | N | 270024389 | CETUXIMAB + OXALIPLATIN + MDG |
| 270010878 | 270006413 | null | 94.3 | Adjuvant (A) | null | 2016-07-26 | HD Lymph Pred EuroNet-PHL-LP1 CVP | null | null | 270024404 | CHOP |
| 270010879 | 270006413 | 0 | 108 | Curative (C) | 2018-04-27 | 2018-04-28 | Cisplatin + Etoposide (3 day) | 02 | N | 270024404 | CETUXIMAB |
| 270010880 | 270006413 | 1.75 | null | Palliative (P) | 2018-05-18 | 2018-05-22 | Brentuximab | null | null | 270024404 | CARBOPLATIN |
| 270010881 | 270017915 | 1.73 | 82 | Curative (C) | 2016-02-05 | 2016-02-09 | Cetuximab + Radiotherapy Load | 2 | N | 270024528 | CETUXIMAB |
| 270010882 | 270017915 | 1.65 | 78.8 | Palliative (P) | 2014-06-04 | 2014-06-13 | Carboplatin + Etoposide IV 3 day | N | N | 270024528 | ENZALUTAMIDE |
| 270010883 | 270006414 | 1.67 | null | Curative (C) | 2017-12-12 | 2017-12-17 | CARBOPLATIN + RT | 02 | Y | 270024567 | CETUXIMAB + RT |
| 270010884 | 270006415 | 1.75 | 84 | Curative (C) | 2017-01-23 | 2017-01-24 | null | Y | N | 270024602 | CETUXIMAB + IRINOTECAN + MDG |
| 270010885 | 270006416 | 1.7 | null | Palliative (P) | null | 2017-12-16 | Carboplatin + Pemetrexed | null | null | 270024622 | CARBO + FLUOROURACIL |
| 270010886 | 270006417 | 1.77 | 77.6 | Adjuvant (A) | 2013-04-15 | 2013-04-29 | Cetuximab + FLUOROURACIL + FOLINIC ACID + OXALIPLATIN | N | N | 270024629 | CARBOPLATIN + RT |
| 270010887 | 270006418 | 1.63 | 70.5 | Neo-adjuvant (N) | 2017-08-30 | 2017-09-06 | Carboplatin + Docetaxel | 02 | N | 270024706 | SCOT TRIAL |
| 270010888 | 270013076 | 1.8 | 74.6 | Palliative (P) | 2014-12-05 | 2014-12-08 | Cetuximab + Radiotherapy Load | N | N | 270024718 | CETUXIMAB + CISPLATIN + FU |
| 270010889 | 270013076 | 1.72 | 76.8 | Curative (C) | 2017-01-10 | 2017-01-24 | ECX | N | N | 270024718 | DOCETAXEL |
| 270010890 | 270017916 | 1.56 | 105 | Palliative (P) | 2015-10-30 | 2015-11-14 | DHAP | N | Y | 270024838 | ABVD R |
| 270010891 | 270017916 | 1.7 | 48.8 | Palliative (P) | 2015-01-31 | 2015-02-17 | Cetuximab 7 day (>Cycle 2) | 02 | Y | 270024838 | CARBOPLATIN + VINORELBINE |
| 270010892 | 270006419 | 1.67 | null | Palliative (P) | 2017-10-15 | 2017-10-21 | Carboplatin AUC 6 - 10 | N | N | 270024883 | CETUXIMAB |
| 270010893 | 270006420 | null | null | Curative (C) | 2016-12-20 | 2017-01-18 | Cetuximab + Radiotherapy Load | null | null | 270024963 | CETUXIMAB + RT |
| 270010894 | 270006421 | null | null | Curative (C) | null | 2015-02-05 | Panitumumab | N | N | 270024978 | CARBOPLATIN |
| 270010895 | 270006421 | 1.71 | 102 | Disease modification (D) | 2016-11-02 | 2016-11-09 | ESHAP | 02 | N | 270024978 | CETUXIMAB + OXALIPLATIN + MDG |
| 270010896 | 270006421 | 1.5 | 61 | Neo-adjuvant (N) | 2016-11-10 | 2016-11-16 | TRASTUZUMAB | Y | N | 270024978 | CARBOPLATIN + DOCETAXEL |
| 270010897 | 270006422 | 1.7 | 53 | Palliative (P) | 2017-07-11 | 2017-07-18 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270025265 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270010898 | 270006423 | null | null | Palliative (P) | 2015-06-12 | 2015-06-14 | Bevacizumab + Oxaliplatin +MdG | null | N | 270025268 | CARBO + FLUOROURACIL |
| 270010899 | 270006424 | null | 69.3 | Palliative (P) | 2016-10-27 | 2016-11-03 | Carboplatin AUC 2 - 5 | null | null | 270025280 | CETUXIMAB + CISPLATIN + FU |
| 270010900 | 270006425 | 1.77 | 131 | Adjuvant (A) | 2015-05-27 | 2015-07-16 | Carboplatin AUC 6 - 10 | 02 | N | 270025303 | GEMCARBO |
| 270010901 | 270006426 | 1.73 | 91.5 | Palliative (P) | null | 2017-03-25 | Bevacizumab + Oxaliplatin +MdG | N | N | 270025613 | CETUXIMAB + RT |
| 270010902 | 270006427 | null | null | Palliative (P) | null | 2016-12-19 | Bevacizumab + Cape + Oxali 21day | N | null | 270025696 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270010903 | 270006428 | 1.8 | 47.1 | Adjuvant (A) | 2016-08-19 | 2016-08-19 | Cetuximab + Radiotherapy Maint | 2 | N | 270025801 | CARBOPLATIN |
| 270010904 | 270006429 | 1.5 | null | Palliative (P) | 2013-09-28 | 2013-10-01 | CARBOPLATIN + PACLITAXEL | N | null | 270025860 | CARBOPLATIN |
| 270010905 | 270006430 | 1.78 | 72.6 | null | 2017-07-20 | 2017-07-26 | Carbo F | 2 | N | 270003046 | CISPLATIN + FLUOROURACIL + RT |
| 270010906 | 270006431 | 1.7 | 60 | Curative (C) | 2019-02-27 | 2019-03-15 | Bevacizumab + Cape + Oxali 21day | N | N | 270003466 | CARBOPLATIN + PEMETREXED |
| 270010907 | 270006432 | 1.74 | 118.55 | Palliative (P) | null | 2019-03-10 | Cetuximab + FOLFIRI cycle 2 onwards | 99 | null | 270003504 | CETUXIMAB |
| 270010908 | 270006433 | 1.71 | null | Palliative (P) | null | 2018-09-28 | Cisplatin + Etoposide po&iv 3 day | N | null | 270003570 | CETUXIMAB |
| 270010909 | 270006434 | null | 90 | Curative (C) | 2018-01-11 | 2018-01-16 | Cetuximab + Radiotherapy Maint | N | N | 270003855 | CISPLATIN + ETOPOSIDE |
| 270010910 | 270013078 | 1.63 | 72 | Curative (C) | 2018-07-22 | 2018-09-17 | Fluorouracil + Folinic + RT Bossett | N | N | 270004178 | CETUXIMAB + IRINOTECAN + MDG |
| 270010911 | 270013078 | null | null | Disease modification (D) | 2016-09-16 | 2016-09-20 | ECarboX | N | null | 270004178 | CARBOPLATIN |
| 270010912 | 270013078 | 1.6 | 41.7 | Curative (C) | null | 2017-09-24 | Docetaxel | N | N | 270004178 | CAP + RT |
| 270010913 | 270006435 | 1.5 | 66 | Curative (C) | 2018-06-17 | 2018-06-25 | CVP | N | N | 270005582 | BRENTUXIMAB |